Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment - Precision 1

NCT03873103 is registered in ClinicalTrials.gov with The Belgian Society of Medical Oncology as lead sponsor.

NCT NCT03873103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03873103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment - Precision 1
Lead sponsor
The Belgian Society of Medical Oncology
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2019
Completion date
December 31, 2023
Enrollment
1,000 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer